Evidence map›Paper›PMID 12894850›Full record

ArticleInternational journal of hematology2003

Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency.

Asghar Aghamohammadi, Hirokazu Kanegane, Mostafa Moein, Abolhasan Farhoudi, Zahra Pourpak, Masoud Movahedi, Mohammad Gharagozlou, Ali Akabar Amir Zargar, Toshio Miyawaki

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. History of primary immunodeficiency diseases in iran.Iranian journal of pediatrics · 2010
    Article
  5. Common variable immunodeficiency: etiological and treatment issues.International archives of allergy and immunology · 2009
    Review
  6. Article
  7. Article
  8. Defective B cell responses in the absence of SH2D1A.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Asghar AghamohammadiDepartment of Clinical Pediatric Immunology, Children's Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hirokazu Kanegane
Mostafa Moein
Abolhasan Farhoudi
Zahra Pourpak
Masoud Movahedi
Mohammad Gharagozlou
Ali Akabar Amir Zargar
Toshio Miyawaki
Tehran University of Medical Sciences · IRChildren's Medical Center · IRTohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common variable immunodeficiency (CVID) is a highly heterogeneous disease with an unpredictable pattern. CVID appears to have an immunologic and clinical phenotype similar to some hereditary humoral immunodeficiencies, including X-linked lymphoproliferative disease (XLP). The differential diagnosis of CVID and XLP is clinically of importance, because the two diseases have markedly different prognoses and treatment. The recent identification of the XLP gene, known as SH2D1A, has permitted a definitive diagnosis of XLP. In this report, we describe a male patient with XLP who initially received a diagnosis of CVID and developed a fatal course. Using genetic analysis, we confirmed that the patient harbored the SH2D1A gene mutation. The results support the notion that the possibility of a SH2D1A gene mutation should be considered in hypogammaglobulinemic male patients before a diagnosis of CVID is made.

Indexed as

Intracellular Signaling Peptides and ProteinsMutationAgammaglobulinemiaCarrier ProteinsChildCommon Variable ImmunodeficiencyDiagnosis, DifferentialDNA Mutational AnalysisFatal OutcomeHumansLymphoproliferative DisordersMaleSignaling Lymphocytic Activation Molecule Associated ProteinCarrier ProteinsIntracellular Signaling Peptides and ProteinsSH2D1A protein, humanSignaling Lymphocytic Activation Molecule Associated Protein

Identifiers

PMID12894850
OpenAlexW2043699657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.